Skip to main content
ConductScienceScienceDex

Deyu Fang

FY2026 NIH rank #6,934
Unclaimed recordClaim profile
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7261033Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-4211-2751Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Physiology
  • Pathology

NIH Funding · FY2026

Linked Award Amount
$2.7M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#6,934
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Deyu Fang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$1.3M

2 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Deyu Fang as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI167272-05R01
    Clinical analysis and therapeutic development of exosomal ACE2
    Northwestern University
    $697.5K
    award amount
  • 5R01DK120330-08R01
    Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism
    University of Virginia
    $683.7K
    award amount
  • 1R01CA309466-01A1R01
    Development of FoxP3-specific Degraders for Antitumor Immunotherapy
    Northwestern University
    $656.3K
    award amount
  • 5R01CA288387-02R01
    Develop a novel therapy with immuno- and onco-targeting dual efficacies to treat the triple negative breast cancer
    Northwestern University
    $646.1K
    award amount

Award organizations

Organizations that administered FY2026 awards listing Deyu Fang as a PI.

Northwestern University
IL
$2M
3 grants
University of Virginia
VA
$683.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Northwestern University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2562
  6. 2024
    Entered Top 25% Nationally
    Ranked #2562
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Entered Top 10% Nationally
    Ranked #1716
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Deyu Fang.

Huiping Liu
Northwestern University
5
shared awards
Ling Qi
University of Virginia
3
shared awards
Bin Zhang
Northwestern University
2
shared awards
Li Zhou
Henry Ford Health + Michigan State University Health Sciences
2
shared awards
Qing-sheng Mi
Henry Ford Health + Michigan State University Health Sciences
2
shared awards
Chad A. Mirkin
Northwestern University
1
shared award
Kezhong Zhang
Wayne State University
1
shared award

Explore further

Find collaborators for Deyu Fang

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →